WAKAMOTO PHARMACEUTICAL CO revenue for the last year amounted to 8.66 B JPY, the most of which — 4.46 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 5.15 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought WAKAMOTO PHARMACEUTICAL CO 7.47 B JPY, and the year before that — 8.38 B JPY.